Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Alexander van Akkooi MD, PhD, FRACS
Alexander C. J. van Akkooi MD, PhD, FRACS Associate Editor
Eric Jonasch MD
Eric Jonasch MD Advisory Board
Jean-Yves Douillard MD, PhD
Jean-Yves Douillard MD, PhD Advisory Board
See All Experts
featured
Published in Oncology

Expert Opinion / Interview · June 10, 2019

Erlotinib Plus Ramucirumab for EGFR Mutant Lung Cancer

Farzanna Haffizulla MD, FACP, FAMWA
Sarah Goldberg MD, MPH

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Sarah Goldberg MD, MPH

Further Reading

Related Videos